Bone Marrow Stimulation Does Not Improve Outcomes in Rotator Cuff Repair, reveals study

• No significant differences in range of motion, ASES scores, constant scores, or VAS scores between groups over 2 years (all p>0.05).

• Similar rotator cuff retear rates between BMS and control groups at 6 months and 2 years post-surgery (all p>0.05).

• Both groups showed similar improvements over the 2-year follow-up period. There were no significant differences between the BMS and control groups in range of motion, ASES scores, constant scores, or VAS scores (all p>0.05).

• Ultrasound assessments revealed no significant difference in the rotator cuff retear rate between the two groups at 6 months and 2 years post-surgery (all p>0.05).

The study's findings indicate that BMS does not offer additional benefits when combined with ARCR in terms of clinical and structural outcomes. Despite theoretical advantages, the practical impact of BMS on postoperative recovery appears minimal.

The inclusion of BMS in ARCR for patients with small to large rotator cuff tears does not significantly affect postoperative outcomes. Therefore, BMS may not be necessary for improving clinical and functional recovery in these patients.

Reference:

Hong, K.-B., Lee, T.-H., Park, H.-K., Lee, J.-H., Chung, S.-W., & Park, J.-Y. (2024). The impact of bone marrow stimulation on arthroscopic rotator cuff repair for small to large rotator cuff tears: A randomized controlled trial. Et al [Journal of Shoulder and Elbow Surgery]. https://doi.org/10.1016/j.jse.2024.03.048